These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 35537426)
1. The Role of Long-Chain Polyunsaturated Fatty Acids in Very Preterm Nutrition. McPhee AJ; Collins CT; Gibson RA; Makrides M Nestle Nutr Inst Workshop Ser; 2021; 96():107-115. PubMed ID: 35537426 [TBL] [Abstract][Full Text] [Related]
2. Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review. Zhang P; Lavoie PM; Lacaze-Masmonteil T; Rhainds M; Marc I Pediatrics; 2014 Jul; 134(1):120-34. PubMed ID: 24913791 [TBL] [Abstract][Full Text] [Related]
3. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions. Skouroliakou M; Konstantinou D; Agakidis C; Delikou N; Koutri K; Antoniadi M; Karagiozoglou-Lampoudi T Nutr Clin Pract; 2012 Dec; 27(6):817-24. PubMed ID: 22878361 [TBL] [Abstract][Full Text] [Related]
4. The role of long chain polyunsaturated fatty acids in perinatal nutrition. Collins CT; Gibson RA; McPhee AJ; Makrides M Semin Perinatol; 2019 Nov; 43(7):151156. PubMed ID: 31326100 [TBL] [Abstract][Full Text] [Related]
5. Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial. Gould JF; Colombo J; Collins CT; Makrides M; Hewawasam E; Smithers LG BMJ Open; 2018 May; 8(5):e020043. PubMed ID: 29804059 [TBL] [Abstract][Full Text] [Related]
6. Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial. Najm S; Löfqvist C; Hellgren G; Engström E; Lundgren P; Hård AL; Lapillonne A; Sävman K; Nilsson AK; Andersson MX; Smith LEH; Hellström A Clin Nutr ESPEN; 2017 Aug; 20():17-23. PubMed ID: 29072164 [TBL] [Abstract][Full Text] [Related]
7. Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates. Staub E; Evers K; Askie LM Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012797. PubMed ID: 33710626 [TBL] [Abstract][Full Text] [Related]
8. Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial. Gould JF; Makrides M; Sullivan TR; Anderson PJ; Gibson RA; Best KP; McPhee AJ; Doyle LW; Opie G; Travadi J; Cheong J; Davis PG; Sharp M; Simmer K; Collins CT BMJ Open; 2021 Feb; 11(2):e041597. PubMed ID: 33550243 [TBL] [Abstract][Full Text] [Related]
9. Extremely preterm infants receiving standard care receive very low levels of arachidonic and docosahexaenoic acids. De Rooy L; Hamdallah H; Dyall SC Clin Nutr; 2017 Dec; 36(6):1593-1600. PubMed ID: 27756480 [TBL] [Abstract][Full Text] [Related]
10. Long-Chain Polyunsaturated Fatty Acids and Clinical Outcomes of Preterm Infants. Lapillonne A; Moltu SJ Ann Nutr Metab; 2016; 69 Suppl 1():35-44. PubMed ID: 27842316 [TBL] [Abstract][Full Text] [Related]
11. Omega-3 Long-chain Polyunsaturated Fatty Acids for Bronchopulmonary Dysplasia: A Meta-analysis. Wang Q; Zhou B; Cui Q; Chen C Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31164440 [TBL] [Abstract][Full Text] [Related]
12. Influence of Human Milk and Parenteral Lipid Emulsions on Serum Fatty Acid Profiles in Extremely Preterm Infants. Nilsson AK; Löfqvist C; Najm S; Hellgren G; Sävman K; Andersson MX; Smith LEH; Hellström A JPEN J Parenter Enteral Nutr; 2019 Jan; 43(1):152-161. PubMed ID: 29679529 [TBL] [Abstract][Full Text] [Related]
13. Association of Retinopathy of Prematurity With Low Levels of Arachidonic Acid: A Secondary Analysis of a Randomized Clinical Trial. Löfqvist CA; Najm S; Hellgren G; Engström E; Sävman K; Nilsson AK; Andersson MX; Hård AL; Smith LEH; Hellström A JAMA Ophthalmol; 2018 Mar; 136(3):271-277. PubMed ID: 29423508 [TBL] [Abstract][Full Text] [Related]
14. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585 [TBL] [Abstract][Full Text] [Related]
15. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation. Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS; BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120 [TBL] [Abstract][Full Text] [Related]
16. Summary Protocol for a Multi-Centre Randomised Controlled Trial of Enteral Lactoferrin Supplementation in Newborn Very Preterm Infants (ELFIN). The ELFIN Trial Investigators Group Neonatology; 2018; 114(2):142-148. PubMed ID: 29890513 [TBL] [Abstract][Full Text] [Related]